6505--Hydralazine HCL Tablets Effective 04/08/2026 to 04/07/2027 36E79725R0060
Summary
AI-generated · Oct 22, 2025Supply Hydralazine hydrochloride tablets in multiple strengths (10 mg, 25 mg, 50 mg, 100 mg) and package sizes (100-count and 1,000-count bottles) to ensure an uninterrupted source of supply under a single award. Packaging must be non-glass; bidders must specify the exact label name and provide a unique NDC number for each item. Products will be distributed through the Prime Vendor Programs used by the participating federal entities.
The contract will cover a 1-year base period with four 1-year options. The acquisition is unrestricted and open to all responsible sources, with proposals submitted electronically in commercial item format (no paper copies). Estimated annual requirements by strength and package size are: 100 mg/100-count bottles: 103,773; 10 mg/100-count: 6,279; 10 mg/1,000-count: 12,283; 25 mg/100-count: 6,188; 25 mg/1,000-count: 29,343; 50 mg/100-count: 5,481; 50 mg/1,000-count: 28,046.
Page 2 of 2 Page 2 of 2 PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79725R0060 for an unrestricted procurement for Hydralazine tablets, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Glass bottles are not acceptable. Solicitation # 36E79725R0060 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about 10/22/2025 with a tentative closing date of 11/05/2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Amber Zavala. Questions can be e-mailed to: amber.zavala@va.gov. The estimated annual requirements are as follows: Description Size Estimated Annual Requirements (Bottle) HYDRALAZINE HCL 100MG TAB 100 103,773 HYDRALAZINE HCL 10MG TAB 100 6,279 HYDRALAZINE HCL 10MG TAB 1000 12,283 HYDRALAZINE HCL 25MG TAB 100 6,188 HYDRALAZINE HCL 25MG TAB 1000 29,343 HYDRALAZINE HCL 50MG TAB 100 5,481 HYDRALAZINE HCL 50MG TAB 1000 28,046
From Presolicitation posted on Oct 21, 2025n/a
From Solicitation posted on Oct 23, 2025n/a
From Solicitation posted on Nov 05, 2025n/a
From Award Notice posted on Feb 04, 2026Notice history
4-
-
Solicitation Posted Oct 23, 2025View changes (4)
- Description: Description was updated
- Notice Type: Presolicitation → Solicitation
- Response Deadline: Nov 12, 2025 → Nov 06, 2025
- Set-Aside: None → None
-
Award Notice LATEST Posted Feb 04, 2026
Details
Award Information
Award Notices
Posted: Feb 04, 2026
n/a
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| RADHA PHARMACEUTICALS INC | C1S5SQ88KY67 | 8PNH3 | HAUPPAUGE |
Contacts
Amber Zavala
Phone